CST1 and triple-negative breast carcinoma: However, the expression of CST1 had no significant correlation with age, menopause, pathological LN infiltrated, tumor location, ER status, PR status, triple-negative breast cancer, pathological tumor status, and pathological TNM staging (all p > 0.05).